Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Glaxo's Relenza Gets European Approval | Contract Pharma

What are you searching for?

Sign in
Breaking News, Trials & Filings

Glaxo’s Relenza Gets European Approval

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

GlaxoSmithKline received approval for Relenza antiviral treatment for use in the prevention of influenza in 15 European countries. Relenza may be given to adults and children age five and older to prevent flu. The drug, which is inhaled, was also approved for treating flu in children age 5 and older. Relenza was previously approved in Europe for the treatment of flu in adults and children age 12 and older.

Relenza received FDA approval for the prevention of influenza in adults and children 5 and older this past March.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters